329 related articles for article (PubMed ID: 10855766)
21. Valacyclovir and acyclovir for suppression of shedding of herpes simplex virus in the genital tract.
Gupta R; Wald A; Krantz E; Selke S; Warren T; Vargas-Cortes M; Miller G; Corey L
J Infect Dis; 2004 Oct; 190(8):1374-81. PubMed ID: 15378428
[TBL] [Abstract][Full Text] [Related]
22. Herpes Simplex Virus Shedding Rate: Surrogate Outcome for Genital Herpes Recurrence Frequency and Lesion Rates, and Phase 2 Clinical Trials End Point for Evaluating Efficacy of Antivirals.
Agyemang E; Magaret AS; Selke S; Johnston C; Corey L; Wald A
J Infect Dis; 2018 Oct; 218(11):1691-1699. PubMed ID: 30020484
[TBL] [Abstract][Full Text] [Related]
23. One-day regimen of valacyclovir for treatment of recurrent genital herpes simplex virus 2 infection.
Bavaro JB; Drolette L; Koelle DM; Almekinder J; Warren T; Tyring S; Wald A
Sex Transm Dis; 2008 Apr; 35(4):383-6. PubMed ID: 18362859
[TBL] [Abstract][Full Text] [Related]
24. A randomised placebo-controlled trial to explore the effect of suppressive therapy with acyclovir on genital shedding of HIV-1 and herpes simplex virus type 2 among Zimbabwean sex workers.
Cowan FM; Pascoe SJ; Barlow KL; Langhaug LF; Jaffar S; Hargrove JW; Robinson NJ; Bassett MT; Wilson D; Brown DW; Hayes RJ
Sex Transm Infect; 2008 Dec; 84(7):548-53. PubMed ID: 18684855
[TBL] [Abstract][Full Text] [Related]
25. Asymptomatic shedding of herpes simplex virus 1 and 2: implications for prevention of transmission.
Mertz GJ
J Infect Dis; 2008 Oct; 198(8):1098-100. PubMed ID: 18783317
[No Abstract] [Full Text] [Related]
26. Subclinical Genital Herpes Shedding in HIV/Herpes Simplex Virus 2-Coinfected Women during Antiretroviral Therapy Is Associated with an Increase in HIV Tissue Reservoirs and Potentially Promotes HIV Evolution.
Stinn T; Kuntz S; Varon D; Huang ML; Selke S; Njikan S; Ford ES; Dragavon J; Coombs RW; Johnston C; Bull ME
J Virol; 2020 Dec; 95(1):. PubMed ID: 33028713
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of N-methanocarbathymidine against genital herpes simplex virus type 2 shedding and infection in guinea pigs.
Bernstein DI; Bravo FJ; Pullum DA; Shen H; Wang M; Rahman A; Glazer RI; Cardin RD
Antivir Chem Chemother; 2015 Feb; 24(1):19-27. PubMed ID: 26149263
[TBL] [Abstract][Full Text] [Related]
28. Reducing the risk of transmitting genital herpes: advances in understanding and therapy.
Leone P
Curr Med Res Opin; 2005 Oct; 21(10):1577-82. PubMed ID: 16238897
[TBL] [Abstract][Full Text] [Related]
29. Comparative efficacy of famciclovir and valacyclovir for suppression of recurrent genital herpes and viral shedding.
Wald A; Selke S; Warren T; Aoki FY; Sacks S; Diaz-Mitoma F; Corey L
Sex Transm Dis; 2006 Sep; 33(9):529-33. PubMed ID: 16540883
[TBL] [Abstract][Full Text] [Related]
30. Virologic characteristics of subclinical and symptomatic genital herpes infections.
Wald A; Zeh J; Selke S; Ashley RL; Corey L
N Engl J Med; 1995 Sep; 333(12):770-5. PubMed ID: 7643884
[TBL] [Abstract][Full Text] [Related]
31. Oral and Vaginal Tenofovir for Genital Herpes Simplex Virus Type 2 Shedding in Immunocompetent Women: A Double-Blind, Randomized, Cross-over Trial.
Bender Ignacio RA; Perti T; Magaret AS; Rajagopal S; Stevens CE; Huang ML; Selke S; Johnston C; Marrazzo J; Wald A
J Infect Dis; 2015 Dec; 212(12):1949-56. PubMed ID: 26044291
[TBL] [Abstract][Full Text] [Related]
32. Genital Herpes Simplex Virus Type 2 Shedding Among Adults With and Without HIV Infection in Uganda.
Phipps W; Nakku-Joloba E; Krantz EM; Selke S; Huang ML; Kambugu F; Orem J; Casper C; Corey L; Wald A
J Infect Dis; 2016 Feb; 213(3):439-47. PubMed ID: 26486633
[TBL] [Abstract][Full Text] [Related]
33. An update on short-course episodic and prevention therapies for herpes genitalis.
Corey L; Bodsworth N; Mindel A; Patel R; Schacker T; Stanberry L
Herpes; 2007 Jun; 14 Suppl 1():5A-11A. PubMed ID: 17877886
[TBL] [Abstract][Full Text] [Related]
34. Infectious co-factors in HIV-1 transmission herpes simplex virus type-2 and HIV-1: new insights and interventions.
Barnabas RV; Celum C
Curr HIV Res; 2012 Apr; 10(3):228-37. PubMed ID: 22384842
[TBL] [Abstract][Full Text] [Related]
35. Management of herpes simplex virus type 2 infection in HIV type 1-infected persons.
Strick LB; Wald A; Celum C
Clin Infect Dis; 2006 Aug; 43(3):347-56. PubMed ID: 16804851
[TBL] [Abstract][Full Text] [Related]
36. Once daily valacyclovir for reducing viral shedding in subjects newly diagnosed with genital herpes.
Martens MG; Fife KH; Leone PA; Dix LP; Brennan CA
Infect Dis Obstet Gynecol; 2009; 2009():105376. PubMed ID: 19680456
[TBL] [Abstract][Full Text] [Related]
37. Virologic and immunologic evidence of multifocal genital herpes simplex virus 2 infection.
Johnston C; Zhu J; Jing L; Laing KJ; McClurkan CM; Klock A; Diem K; Jin L; Stanaway J; Tronstein E; Kwok WW; Huang ML; Selke S; Fong Y; Magaret A; Koelle DM; Wald A; Corey L
J Virol; 2014 May; 88(9):4921-31. PubMed ID: 24554666
[TBL] [Abstract][Full Text] [Related]
38. Does frequency of genital herpes recurrences predict risk of transmission? Further analysis of the valacyclovir transmission study.
Kim HN; Wald A; Harris J; Almekinder J; Heitman C; Corey L
Sex Transm Dis; 2008 Feb; 35(2):124-8. PubMed ID: 17921912
[TBL] [Abstract][Full Text] [Related]
39. Oral shedding of herpes simplex virus type 1: a review.
Scott DA; Coulter WA; Lamey PJ
J Oral Pathol Med; 1997 Nov; 26(10):441-7. PubMed ID: 9416573
[TBL] [Abstract][Full Text] [Related]
40. Vitamin A supplementation and genital shedding of herpes simplex virus among HIV-1-infected women: a randomized clinical trial.
Baeten JM; McClelland RS; Corey L; Overbaugh J; Lavreys L; Richardson BA; Wald A; Mandaliya K; Bwayo JJ; Kreiss JK
J Infect Dis; 2004 Apr; 189(8):1466-71. PubMed ID: 15073684
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
